Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Free Cash Flow: 2013-2024

Historic Free Cash Flow for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$152.0 million.

  • Wave Life Sciences' Free Cash Flow rose 4.15% to -$44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$198.2 million, marking a year-over-year decrease of 39.73%. This contributed to the annual value of -$152.0 million for FY2024, which is 639.63% down from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Free Cash Flow is -$152.0 million, which was down 639.63% from -$20.5 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Free Cash Flow ranged from a high of -$20.5 million in FY2023 and a low of -$152.0 million during FY2024.
  • Its 3-year average for Free Cash Flow is -$100.6 million, with a median of -$129.1 million in 2022.
  • As far as peak fluctuations go, Wave Life Sciences' Free Cash Flow spiked by 84.09% in 2023, and later crashed by 639.63% in 2024.
  • Over the past 5 years, Wave Life Sciences' Free Cash Flow (Yearly) stood at -$117.3 million in 2020, then rose by 23.67% to -$89.6 million in 2021, then crashed by 44.21% to -$129.1 million in 2022, then spiked by 84.09% to -$20.5 million in 2023, then slumped by 639.63% to -$152.0 million in 2024.